RxDoctor Payments Data

Mandy Newman, APRN

Family · Central City, KYNPI 1710530019

Payments from drug & device makers

$530in general payments, 2019–2025

Across 30 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$186
  • AbbVie$101
  • Lilly USA, LLC$60
  • GSK$43
  • Axsome Therapeutics, Inc.$27
  • AstraZeneca$19
  • plus $94 from 6 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,280
Medicare patients
64
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$80,546
JardianceEmpagliflozin84$56,730
TrulicityDulaglutide18$17,751
JanuviaSitagliptin Phosphate17$13,539
XareltoRivaroxaban16$12,301
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,750
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$9,602
Spiriva RespimatTiotropium Bromide12$7,532
JanumetSitagliptin Phos/Metformin Hcl12$6,739
Tresiba Flextouch U-200Insulin Degludec11$6,574
Pregabalin13$2,046
Albuterol Sulfate HfaAlbuterol Sulfate66$1,883
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$1,713
Duloxetine Hcl80$1,329
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$1,308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$186$80,54685 claims
GSKTrelegy Ellipta, Anoro Ellipta$43$19,35233 claims
Lilly USA, LLCTrulicity$60$17,75118 claims
AbbVieSynthroid$101$42313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Central City

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →